Patents by Inventor Margaret McLaughlin
Margaret McLaughlin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240100010Abstract: Provided herein are drug implants comprising a therapeutically active agent for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and a therapeutically active agent disposed therein. Additionally, provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may comprise bicalutamide, e.g., for use in the treatment of prostate cancer.Type: ApplicationFiled: December 18, 2020Publication date: March 28, 2024Inventors: Carlos Schuler, Maithili Rairkar, Pujan Desai, Maxime Daud, Maxime D. Rappaport, Pamela Munster, John Maroney, Margaret McLaughlin, Tobias H. Casab, Keith Hall, Scott Thomas
-
Publication number: 20230137168Abstract: Provided herein are drug implants comprising a therapeutically active agent for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and a therapeutically active agent disposed therein. Additionally, provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may comprise bicalutamide, e.g., for use in the treatment of prostate cancer.Type: ApplicationFiled: December 18, 2020Publication date: May 4, 2023Inventors: Carlos Schuler, Maithill Rairkar, Pujan Desai, Maxime Daud, Maxime D. Rappaport, Pamela Munster, John Maroney, Margaret McLaughlin, Tobias H. Casab, Keith Hall, Scott Thomas
-
Publication number: 20220377024Abstract: A proactive networking system and method is disclosed. The network anticipates the user demands in advance and utilizes this predictive ability to reduce the peak to average ratio of the wireless traffic and yield significant savings in the required resources to guarantee certain Quality of Service (QoS) metrics. The system and method focuses on the existing cellular architecture and involves the design and analysis of learning algorithms, predictive resource allocation strategies, and incentive techniques to maximize the efficiency of proactive cellular networks. The system and method further involve proactive peer-to-peer (P2P) overlaying, which leverages the spatial and social structure of the network. Machine learning techniques are applied to find the optimal tradeoff between predictions that result in content being retrieved that the user ultimately never requests, and requests that are not anticipated in a timely manner.Type: ApplicationFiled: July 25, 2022Publication date: November 24, 2022Inventors: Hesham El Gamal, Atilla Eryilmaz, Giuseppe Caire, Fei Sha, Margaret McLaughlin
-
Patent number: 11411889Abstract: A proactive networking system and method is disclosed. The network anticipates the user demands in advance and utilizes this predictive ability to reduce the peak to average ratio of the wireless traffic and yield significant savings in the required resources to guarantee certain Quality of Service (QoS) metrics. The system and method focuses on the existing cellular architecture and involves the design and analysis of learning algorithms, predictive resource allocation strategies, and incentive techniques to maximize the efficiency of proactive cellular networks. The system and method further involve proactive peer-to-peer (P2P) overlaying, which leverages the spatial and social structure of the network. Machine learning techniques are applied to find the optimal tradeoff between predictions that result in content being retrieved that the user ultimately never requests, and requests that are not anticipated in a timely manner.Type: GrantFiled: April 6, 2020Date of Patent: August 9, 2022Assignee: OHIO STATE INNOVATION FOUNDATIONInventors: Hesham El Gamal, Atilla Eryilmaz, Giuseppe Caire, Fei Sha, Margaret McLaughlin
-
Patent number: 11344526Abstract: Provided herein are drug implants comprising a therapeutically active agent for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and a therapeutically active agent disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may comprise bicalutamide, e.g., for use in the treatment of prostate cancer.Type: GrantFiled: March 20, 2020Date of Patent: May 31, 2022Assignees: The Regents of the University of California, Alessa Therapeutics, Inc.Inventors: Maithili Rairkar, Pujan Desai, Carlos Schuler, Maxime Daud, Maxime D. Rappaport, Pamela Munster, John Maroney, Margaret McLaughlin, Tobias H. Casab, Keith Hall, Scott Thomas
-
Patent number: 11338119Abstract: Provided herein are drug implants comprising a therapeutically active agent for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and a therapeutically active agent disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may comprise bicalutamide, e.g., for use in the treatment of prostate cancer.Type: GrantFiled: March 20, 2020Date of Patent: May 24, 2022Assignees: The Regents of the University of California, Alessa Therapeutics, Inc.Inventors: Maithili Rairkar, Pujan Desai, Carlos Schuler, Maxime Daud, Maxime D. Rappaport, Pamela Munster, John Maroney, Margaret McLaughlin, Tobias H. Casab, Keith Hall, Scott Thomas
-
Patent number: 11173291Abstract: Provided herein are drug implants comprising a therapeutically active agent for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and a therapeutically active agent disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may comprise bicalutamide, e.g., for use in the treatment of prostate cancer.Type: GrantFiled: March 20, 2020Date of Patent: November 16, 2021Assignees: The Regents of the University of California, Alessa Therapeutics, Inc.Inventors: Maithili Rairkar, Pujan Desai, Carlos Schuler, Maxime Daud, Maxime D. Rappaport, Pamela Munster, John Maroney, Margaret McLaughlin, Tobias H. Casab, Keith Hall, Scott Thomas
-
Publication number: 20210290584Abstract: Provided herein are drug implants comprising a therapeutically active agent for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and a therapeutically active agent disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may comprise bicalutamide, e.g., for use in the treatment of prostate cancer.Type: ApplicationFiled: March 20, 2020Publication date: September 23, 2021Inventors: Maithili Rairkar, Pujan Desai, Carlos Schuler, Maxime Daud, Maxime D. Rappaport, Pamela Munster, John Maroney, Margaret McLaughlin, Tobias H. Casab, Keith Hall, Scott Thomas
-
Publication number: 20210290919Abstract: Provided herein are drug implants comprising a therapeutically active agent for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and a therapeutically active agent disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may comprise bicalutamide, e.g., for use in the treatment of prostate cancer.Type: ApplicationFiled: March 20, 2020Publication date: September 23, 2021Inventors: Maithili Rairkar, Pujan Desai, Carlos Schuler, Maxime Daud, Maxime D. Rappaport, Pamela Munster, John Maroney, Margaret McLaughlin, Tobias H. Casab, Keith Hall, Scott Thomas
-
Publication number: 20210290920Abstract: Provided herein are drug implants comprising a therapeutically active agent for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and a therapeutically active agent disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may comprise bicalutamide, e.g., for use in the treatment of prostate cancer.Type: ApplicationFiled: March 20, 2020Publication date: September 23, 2021Inventors: Maithili Rairkar, Pujan Desai, Carlos Schuler, Maxime Daud, Maxime D. Rappaport, Pamela Munster, John Maroney, Margaret McLaughlin, Tobias H. Casab, Keith Hall, Scott Thomas
-
Publication number: 20200236063Abstract: A proactive networking system and method is disclosed. The network anticipates the user demands in advance and utilizes this predictive ability to reduce the peak to average ratio of the wireless traffic and yield significant savings in the required resources to guarantee certain Quality of Service (QoS) metrics. The system and method focuses on the existing cellular architecture and involves the design and analysis of learning algorithms, predictive resource allocation strategies, and incentive techniques to maximize the efficiency of proactive cellular networks. The system and method further involve proactive peer-to-peer (P2P) overlaying, which leverages the spatial and social structure of the network. Machine learning techniques are applied to find the optimal tradeoff between predictions that result in content being retrieved that the user ultimately never requests, and requests that are not anticipated in a timely manner.Type: ApplicationFiled: April 6, 2020Publication date: July 23, 2020Inventors: Hesham El Gamal, Atilla Eryilmaz, Giuseppe Caire, Fei Sha, Margaret McLaughlin
-
Patent number: 10616138Abstract: A proactive networking system and method is disclosed. The network anticipates the user demands in advance and utilizes this predictive ability to reduce the peak to average ratio of the wireless traffic and yield significant savings in the required resources to guarantee certain Quality of Service (QoS) metrics. The system and method focuses on the existing cellular architecture and involves the design and analysis of learning algorithms, predictive resource allocation strategies, and incentive techniques to maximize the efficiency of proactive cellular networks. The system and method further involve proactive peer-to-peer (P2P) overlaying, which leverages the spatial and social structure of the network. Machine learning techniques are applied to find the optimal tradeoff between predictions that result in content being retrieved that the user ultimately never requests, and requests that are not anticipated in a timely manner.Type: GrantFiled: January 18, 2019Date of Patent: April 7, 2020Assignee: OHIO STATE INNOVATION FOUNDATIONInventors: Hesham El Gamal, Atilla Eryilmaz, Giuseppe Caire, Fei Sha, Margaret McLaughlin
-
Publication number: 20190158426Abstract: A proactive networking system and method is disclosed. The network anticipates the user demands in advance and utilizes this predictive ability to reduce the peak to average ratio of the wireless traffic and yield significant savings in the required resources to guarantee certain Quality of Service (QoS) metrics. The system and method focuses on the existing cellular architecture and involves the design and analysis of learning algorithms, predictive resource allocation strategies, and incentive techniques to maximize the efficiency of proactive cellular networks. The system and method further involve proactive peer-to-peer (P2P) overlaying, which leverages the spatial and social structure of the network. Machine learning techniques are applied to find the optimal tradeoff between predictions that result in content being retrieved that the user ultimately never requests, and requests that are not anticipated in a timely manner.Type: ApplicationFiled: January 18, 2019Publication date: May 23, 2019Inventors: Hesham El Gamal, Atilla Eryilmaz, Giuseppe Caire, Fei Sha, Margaret McLaughlin
-
Patent number: 10187327Abstract: A proactive networking system and method is disclosed. The network anticipates the user demands in advance and utilizes this predictive ability to reduce the peak to average ratio of the wireless traffic and yield significant savings in the required resources to guarantee certain Quality of Service (QoS) metrics. The system and method focuses on the existing cellular architecture and involves the design and analysis of learning algorithms, predictive resource allocation strategies, and incentive techniques to maximize the efficiency of proactive cellular networks. The system and method further involve proactive peer-to-peer (P2P) overlaying, which leverages the spatial and social structure of the network. Machine learning techniques are applied to find the optimal tradeoff between predictions that result in content being retrieved that the user ultimately never requests, and requests that are not anticipated in a timely manner.Type: GrantFiled: June 9, 2017Date of Patent: January 22, 2019Assignee: OHIO STATE INNOVATION FOUNDATIONInventors: Hesham El Gamal, Atilla Eryilmaz, Giuseppe Caire, Fei Sha, Margaret McLaughlin
-
Publication number: 20170279739Abstract: A proactive networking system and method is disclosed. The network anticipates the user demands in advance and utilizes this predictive ability to reduce the peak to average ratio of the wireless traffic and yield significant savings in the required resources to guarantee certain Quality of Service (QoS) metrics. The system and method focuses on the existing cellular architecture and involves the design and analysis of learning algorithms, predictive resource allocation strategies, and incentive techniques to maximize the efficiency of proactive cellular networks. The system and method further involve proactive peer-to-peer (P2P) overlaying, which leverages the spatial and social structure of the network. Machine learning techniques are applied to find the optimal tradeoff between predictions that result in content being retrieved that the user ultimately never requests, and requests that are not anticipated in a timely manner.Type: ApplicationFiled: June 9, 2017Publication date: September 28, 2017Inventors: Hesham El Gamal, Atilla Eryilmaz, Giuseppe Caire, Fei Sha, Margaret McLaughlin
-
Patent number: 9680766Abstract: A proactive networking system and method is disclosed. The network anticipates the user demands in advance and utilizes this predictive ability to reduce the peak to average ratio of the wireless traffic and yield significant savings in the required resources to guarantee certain Quality of Service (QoS) metrics. The system and method focuses on the existing cellular architecture and involves the design and analysis of learning algorithms, predictive resource allocation strategies, and incentive techniques to maximize the efficiency of proactive cellular networks. The system and method further involve proactive peer-to-peer (P2P) overlaying, which leverages the spatial and social structure of the network. Machine learning techniques are applied to find the optimal tradeoff between predictions that result in content being retrieved that the user ultimately never requests, and requests that are not anticipated in a timely manner.Type: GrantFiled: September 28, 2011Date of Patent: June 13, 2017Assignees: OHIO STATE INNOVATION FOUNDATION, UNIVERSITY OF SOUTHERN CALIFRONIAInventors: Hesham El Gamal, Atilla Eryilmaz, Giuseppe Caire, Fei Sha, Margaret McLaughlin
-
Publication number: 20140113600Abstract: A proactive networking system and method is disclosed. The network anticipates the user demands in advance and utilizes this predictive ability to reduce the peak to average ratio of the wireless traffic and yield significant savings in the required resources to guarantee certain Quality of Service (QoS) metrics. The system and method focuses on the existing cellular architecture and involves the design and analysis of learning algorithms, predictive resource allocation strategies, and incentive techniques to maximize the efficiency of proactive cellular networks. The system and method further involve proactive peer-to-peer (P2P) overlaying, which leverages the spatial and social structure of the network. Machine learning techniques are applied to find the optimal tradeoff between predictions that result in content being retrieved that the user ultimately never requests, and requests that are not anticipated in a timely manner.Type: ApplicationFiled: September 28, 2011Publication date: April 24, 2014Applicant: THE OHIO STATE UNIVERSITYInventors: Hesham El Gamal, Atilla Eryilmaz, Giuseppe Caire, Fei Sha, Margaret McLaughlin
-
Publication number: 20120202843Abstract: Methods of diagnosing and monitoring cancers and precancerous lesions associated with human papillomavirus (HPV), by detecting abnormal levels of lysine (K)-specific demethylase 6A (KDM6A), KDM6B, or trimethylated Histone H3 Lys27 (H3K27me3).Type: ApplicationFiled: July 14, 2010Publication date: August 9, 2012Applicant: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.Inventors: Karl Munger, Christopher Crum, Margaret McLaughlin-Drubin
-
Publication number: 20100305664Abstract: An implantable medical device is provided for the treatment of a variety of disorders. The implantable medical device can be a neurostimulator having a stimulation lead and electrode(s) configured to be implanted on or near neural tissue in communication with the adrenal gland. Application of an electrical waveform to the neural tissue can cause the adrenal gland to release catecholamines to treat hypoglycemia. In other embodiments, chemical, magnetic, optical, or mechanical neuromodulation can be used.Type: ApplicationFiled: June 1, 2010Publication date: December 2, 2010Inventors: Brett M. Wingeier, Benjamin David Pless, Anthony V. Caparso, Margaret McLaughlin
-
Publication number: 20050026878Abstract: The invention features methods for treating and preventing a peripheral nerve sheath tumor in a mammal such as a human. The methods involve administering to the mammal a compound that modulates the biological activity of a gonatropic steroid receptor, such as the progesterone receptor in an amount sufficient to inhibit the growth of the peripheral nerve sheath tumor. The mammal may be administered with the compound alone or in combination with a second therapeutic regimen. Also disclosed are screening methods that make use of gonatropic steroid receptors for the identification of novel therapeutics for PNSTs.Type: ApplicationFiled: July 24, 2003Publication date: February 3, 2005Inventors: Margaret McLaughlin, Tyler Jacks